Figure 1. Overly broad psychedelic patent document trends. The number of filed patent documents and granted patents by year that contain claims describing information currently in the public domain on LSD, psilocybin, DMT, 5-MeO-DMT, and mescaline (A). The focus of the claims these documents contain, which falls into one or more (multiple) categories, or bins—including methods of using psychedelics for the treatment of a disease or disorder (treatment), how psychedelics are formulated or delivered (delivery), method of producing and isolating psychedelic compounds (production), and combinations of psychedelics with other conventional and unconventional drugs (combinations) (B). The owners (assignees) of these overly broad patent documents (C).